Flecainide How and When: A Practical Guide in Supraventricular Arrhythmias

Area of Science:

• Cardiology
• Pharmacology

Background:

• Transcatheter ablation is increasingly used for supraventricular arrhythmias.
• Antiarrhythmic drugs remain crucial in patient management, often combined with other therapies.

Purpose of the Study:

• To review the characteristics and optimal clinical use of flecainide.
• To delineate flecainide's indications, contraindications, and monitoring based on recent evidence.
• To re-evaluate flecainide's role in light of the CAST trial and new patient data.

Main Methods:

• Literature review of recent studies and evidence.
• Analysis of flecainide's effectiveness and safety profile in diverse patient populations.
• Examination of clinical trial data, including the CAST trial.

Main Results:

• Flecainide is effective for sinus rhythm maintenance in atrial fibrillation (AF) patients without structural cardiomyopathy.
• Recent studies suggest a good effectiveness and safety profile in broader patient groups.
• Optimal use requires careful consideration of indications, contraindications, and monitoring.

Conclusions:

• Flecainide remains a valuable option for AF management.
• Further research may support expanded indications for flecainide.
• Evidence supports individualized patient selection and monitoring for optimal flecainide therapy.